Literature DB >> 21365525

[Personalized, targeted treatment of non-small cell lung cancer].

J Wolf1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21365525     DOI： 10.1055/s-0031-1274531

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN： 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  1 in total

1.  Cost Saving Opportunities in NSCLC Therapy by Optimized Diagnostics.

Authors:  Ilija Nenadić; Jeanine Staber; Susanne Dreier; Guus Simons; Verena Schildgen; Michael Brockmann; Oliver Schildgen
Journal:  Cancers (Basel)       Date:  2017-07-11       Impact factor: 6.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.